Jacob Glanville
Jacob Glanville is an Entrepreneur and Computational Immuno-Engineer. As Founder, CEO and President of Centivax, he enjoys collaborating with multiple partners to generate exciting new technologies in biomedicine.
Centivax
Universal Immunity
-
Imagine a world where infectious diseases can be neutralized before they become global threats—where immunity isn't reactive, but universal. This session explores groundbreaking advancements in biotechnology, rapid-response platforms, and global health strategies that aim to provide immediate protection against emerging pathogens. From engineered antibodies and synthetic vaccines to decentralized diagnostics and equitable healthcare distribution, join the conversation on how science, innovation, and collaboration could revolutionize humanity's defense against the next pandemic.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495